ES2117551A1 - Naphthalene quinolines having leukotriene-antagonistic action - Google Patents

Naphthalene quinolines having leukotriene-antagonistic action

Info

Publication number
ES2117551A1
ES2117551A1 ES09502547A ES9502547A ES2117551A1 ES 2117551 A1 ES2117551 A1 ES 2117551A1 ES 09502547 A ES09502547 A ES 09502547A ES 9502547 A ES9502547 A ES 9502547A ES 2117551 A1 ES2117551 A1 ES 2117551A1
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
quinolines
leukotriene
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09502547A
Other languages
Spanish (es)
Other versions
ES2117551B1 (en
Inventor
Casellas David Mauleon
Avellana Jaime Pascual
Perez M Luisa Garcia
Benet Albert Palomer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to ES9502547A priority Critical patent/ES2117551B1/en
Priority to PCT/EP1996/005811 priority patent/WO1997024331A1/en
Priority to AU13783/97A priority patent/AU1378397A/en
Priority to EP96944059A priority patent/EP0874826A1/en
Publication of ES2117551A1 publication Critical patent/ES2117551A1/en
Application granted granted Critical
Publication of ES2117551B1 publication Critical patent/ES2117551B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/54—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to novel naphthalene quinolines of formula (I), wherein the substituent containing A is bound to the 6- or 7-position of the 2-naphthol system -R<1>, R<2>, R<6> are independently hydrogen, fluorine, chlorine, bromine, -OCH3 or (C1-C4)-alkyl R<3> is hydrogen or methyl R<4>, R<5> are independently hydrogen, -OH, -NH2, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-alkylamino, (C1-C4)-alkoxycarbonyl, (C1-C4)-alkylcarbonylamino, (C1-C4)-alkoxycarbonylalkyl, carbamoyl, carbamoylalkyl, N,N-dialkylcarbamoylalkyl -A- is a diradical -O-, -S-, -SO2-, -SO-, -SO2NR<7>- or -NR<7>SO2- wherein R<7> is hydrogen or (C1-C4)-alkyl B is a sulfur or oxygen atom or a -SO2- or -SO- group or a single bond D is a 5-tetrazolyl or -COOR<8> group, wherein R<8> is hydrogen, a (C1-C4)-alkyl or a phenylalkyl group of less than 10 carbon atoms m is an integer from 0 to 4 n and p are integers from 0 to 6, with the proviso that n + p is less or equal to 6. Said compounds show a leukotriene-antagonistic activity, and they are valuable as anti-inflammatory and antiallergic medicaments or in the treatment of cardiovascular diseases.
ES9502547A 1995-12-29 1995-12-29 NAPHTHALENIC QUINOLINS WITH ANTAGONIST ACTION OF THE LEUKOTRENEES, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME. Expired - Fee Related ES2117551B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES9502547A ES2117551B1 (en) 1995-12-29 1995-12-29 NAPHTHALENIC QUINOLINS WITH ANTAGONIST ACTION OF THE LEUKOTRENEES, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME.
PCT/EP1996/005811 WO1997024331A1 (en) 1995-12-29 1996-12-23 Naphthalene quinolines having leukotriene-antagonistic action
AU13783/97A AU1378397A (en) 1995-12-29 1996-12-23 Naphthalene quinolines having leukotriene-antagonistic action
EP96944059A EP0874826A1 (en) 1995-12-29 1996-12-23 Naphthalene quinolines having leukotriene-antagonistic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9502547A ES2117551B1 (en) 1995-12-29 1995-12-29 NAPHTHALENIC QUINOLINS WITH ANTAGONIST ACTION OF THE LEUKOTRENEES, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME.

Publications (2)

Publication Number Publication Date
ES2117551A1 true ES2117551A1 (en) 1998-08-01
ES2117551B1 ES2117551B1 (en) 1999-04-01

Family

ID=8292586

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9502547A Expired - Fee Related ES2117551B1 (en) 1995-12-29 1995-12-29 NAPHTHALENIC QUINOLINS WITH ANTAGONIST ACTION OF THE LEUKOTRENEES, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME.

Country Status (4)

Country Link
EP (1) EP0874826A1 (en)
AU (1) AU1378397A (en)
ES (1) ES2117551B1 (en)
WO (1) WO1997024331A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1177176E (en) * 1999-04-28 2006-08-31 Aventis Pharma Gmbh DERIVATIVES OF TRIARILIC ACIDS AS LIGANDS OF PPAR RECEPTORS.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315399A2 (en) * 1987-11-03 1989-05-10 Rhone-Poulenc Rorer International (Holdings) Inc. Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same
WO1989005294A1 (en) * 1987-12-01 1989-06-15 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis Substituted quinolines
WO1989012628A1 (en) * 1988-06-21 1989-12-28 Rorer International (Overseas) Inc. Quinoline derivatives as antagonists of leukotriene d4
US5084575A (en) * 1987-07-31 1992-01-28 American Home Products Corporation Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
ES2103181B1 (en) * 1994-08-01 1998-04-01 Menarini Lab NAFTALENIC AMIDES WITH ANTAGONIST ACTION OF THE LEUKOTRENEES.
ES2103180B1 (en) * 1994-08-01 1998-04-01 Menarini Lab PHENYLACETAMIDES WITH ANTAGONIST ACTION OF THE LEUCOTRENEES.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084575A (en) * 1987-07-31 1992-01-28 American Home Products Corporation Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
EP0315399A2 (en) * 1987-11-03 1989-05-10 Rhone-Poulenc Rorer International (Holdings) Inc. Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same
WO1989005294A1 (en) * 1987-12-01 1989-06-15 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis Substituted quinolines
WO1989012628A1 (en) * 1988-06-21 1989-12-28 Rorer International (Overseas) Inc. Quinoline derivatives as antagonists of leukotriene d4

Also Published As

Publication number Publication date
WO1997024331A1 (en) 1997-07-10
ES2117551B1 (en) 1999-04-01
AU1378397A (en) 1997-07-28
EP0874826A1 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
CA2078759A1 (en) Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
DK0749437T3 (en) Pharmaceutical use of steroid derivatives
AU5165393A (en) Substituted benzylaminoquinuclidines as substance p antagonists
AU4640899A (en) Crosslinkable liquid crystalline compounds
HUP0002476A2 (en) Amine compounds, their production and use
IL108769A0 (en) Spirocyclic piperidine derivatives
HUP0300207A2 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
HUP0102723A2 (en) New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them
DE69311837D1 (en) Steroids for the treatment of prostatic hypertrophy, their production and use
ATE25682T1 (en) INDOL-3-CARBOXAMIDE DERIVATIVES.
ES2127106A1 (en) Benzopyran derivatives having leukotriene-antagonistic action
ATE121385T1 (en) UREA DERIVATIVES, THEIR PRODUCTION AND THEIR USE IN THERAPY.
ES2117551A1 (en) Naphthalene quinolines having leukotriene-antagonistic action
ES8506575A1 (en) New phenylalkanoic acid derivatives, their preparation and use.
GR3036462T3 (en) Naphthalene amides having leukotriene-antagonistic action
ES8607338A1 (en) N6-bicycloadenosines.
PL307229A1 (en) Anti-inflammatory derivatives of indolinyl-n-hydroxycarbamide and n-hydroxamic acid
AU572147B2 (en) Dibenzopyran derivatives
ES2103180A1 (en) Phenylacetamides having leukotriene-antagonistic action
ATE160567T1 (en) PSORALEN DERIVATIVES, THEIR PRODUCTION AND USE AS MEDICINAL PRODUCTS
GB1299417A (en) Fluoranthene bis-basic ethers and thioethers

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980801

Kind code of ref document: A1

Effective date: 19980801

FD1A Patent lapsed

Effective date: 20051230